Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary.
Sontheimer
R D
RD
Department of Dermatology, The University of Iowa College of Medicine/The University of Iowa Health Care, Iowa City, IA 52242-1090, USA. richard-sontheimer@uiowa.edu
D000962:Antimalarials / Q000009:adverse effects*; D003695:Delivery of Health Care; D006403:Hematologic Tests / Q000191:economics; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy*; D014481:United States
D000962:Antimalarials; D006886:Hydroxychloroquine